The purpose of this webinar is to discuss the FDA’s voluntary medical device manufacturing and product quality pilot program, CMMI Institute’s role in it and how manufacturers will benefit from this program.
Pharmaceutical remediation is a high-stakes process. Whether it stems from an FDA warning letter, regulatory ...
